Cardiovascular Devices

Format: 2016-10-21
Format: 2016-10-21
October 21, 2016 | 60 Pages | SKU: IRTNTR8579

Outlook of the global postpartum hemorrhage market

Technavio’s market research analyst predicts the global postpartum hemorrhage (PPH) market to grow steadily at a CAGR of around 5% during the forecast period. PPH is the major cause of maternal mortality worldwide. According to CDC estimates, PPH occurs in approximately 18% of total births and accounts for  60% of all maternal deaths. Factors such as the increasing prevalence of PPH in various countries and escalating risk factors associated with PPH will aid in the growth of this market during the predicted period.

In this market study, analysts have estimated that the increasing awareness about PPH would impel market growth during the forecast period. In countries where PPH is a major problem, the issue is frequently well known, but it becomes more prominent when the bleeding is too much. The barriers to PPH prevention and management are larger economic, geographical, and social issues. However, with the advent of organizations like FIGO, the level of awareness among people regarding the prevention and treatment of PPH will also increase. FIGO endorses international recommendations that highlight the provision of skilled birth helpers and upgraded obstetric services as central to efforts to decrease maternal and neonatal mortality.

Product-based segmentation of the postpartum hemorrhage market

  • Uniject prefilled injection system
  • Non-pneumatic anti-shock garment
  • Uterine balloon tamponade

The global market for PPH is dominated by the uterine balloon tamponade segment, which accounted for a market share of more than 46% in 2015. A uterine balloon tamponade is easy-to-use and minimally invasive as it involves the insertion of a balloon device into the uterus to stop the bleeding. Its ability to function as an effective second-line

September 07, 2016 | 80 Pages | SKU: IRTNTR10126

Overview of the global vascular guidewires market

The market research analyst at Technavio predicts that the global vascular guidewires market will grow steadily and post a moderate CAGR of around 6% by 2020. One of the major factors positively affecting this market’s growth will be the growing demand for minimally invasive (MI) procedures. The rising demand for MI procedures will be due to benefits such as faster recovery time, less pain, fewer post-surgery infections, reduced hospital stays, reduced incision marks, bleeding control, minimal complications, and heightened accuracy. Advances in surgical techniques and improvements in equipment handling results help in enhancing surgical precision with a 3D view of the patient; thus, allowing manipulation of small surgical tools for the placement of stents in the individual's body. Also, the usage of guidewires made of materials that provide better flexibility, support, and tracking of the stent during the procedure will lead to the accurate placement of stents as they allow distal device delivery and catheter exchange without the loss of distal wire position.

During 2015, the Americas dominated the market, accounting for approximately 48% of the total market share. The adoption of technologically advanced interventional vascular devices will contribute to the growth of the market. The vendors will invest in research and development of services with advanced medical technologies that will help improve patient outcomes during surgeries, which, in turn, will lead to the progression of the market during the forecast period.

Competitive landscape and key vendors

The market appears fragmented due to the presence of several vendors consisting of both regional and local players who compete to introduce low-cost vascular guidewires. Vendors are investing in resources for the development of products with advanced features such as

August 29, 2016 | 93 Pages | SKU: IRTNTR10032

Overview of the global ventricular assist devices (VADs) market

According to the market research analysts at Technavio, the ventricular assist devices (VADs) market is expected to witness rapid growth at a staggering CAGR of more than 12% over the forecast period. Due to an impending shortage of heart donors and the high cost of heart transplantation, the VADs market is anticipated to have a positive outlook in the coming years. Cardiovascular diseases sometimes lead to heart failure, and it becomes imperative for the patient to undergo heart transplantation. However, it is quite difficult to get a heart transplant due to the shortage of heart donors. It has been observed that with each year, the number of people who require heart transplants is rising, while only a few donors are available. This has resulted in an increase in the average waiting time for heart transplantation. Moreover, heart transplantation procedures are very expensive, making them unaffordable for many people, thereby leading to an augmented demand for VADs. Many people are using VADs due to their cost-effectiveness and easy availability. Unlike artificial hearts, VADs help the heart rest after cardiac surgeries and can also be implanted in people awaiting donor hearts and for long-term use in individuals with advanced congestive heart failure.

Small companies are forming partnerships with hospitals and other companies to develop advanced technologies for market entry. However, only a few products are in their development stage or have received regulatory approval in one region. These products are highly advanced and specific to the preference of physicians. Post approval, these advanced devices will be increasingly adopted and will pose a serious threat to large companies such as Thoratec and ABIOMED. This will bolster the growth prospects for this market during the predicted period.

August 29, 2016 | 87 Pages | SKU: IRTNTR10093

Overview of the global angioplasty balloons market

Comprehensive market research carried out by the analysts at Technavio has shown that the global market for angioplasty balloons will grow at a moderate CAGR of over 3% during 2016 to 2020. Much of this market’s growth can be attributed to the recent emergence of digital cath labs in hospitals. Cath labs or cardiac catheterization laboratories in hospitals have the capability to carry out diagnostic and therapeutic procedures, and can also be used to conduct normal procedures such as the monitoring of blood flow and heart pressure. Recent advances in technology, especially in the area of catheterization, like robot-assisted catheterization for percutaneous coronary intervention (PCI), has led to the development of advanced digital imaging systems. As these systems help to improve the detection and intervention of cardiac diseases, its demand among the healthcare end users will rise substantially over the next four years.

This market study considers three key regions to estimate this market’s growth rate during the forecast period. Out of the three regions considered for estimating this market’s growth potential, the Americas is predicted to account for more than 40% of the overall market share by 2020. The strong growth of this market in the Americas can be attributed to the high adoption of balloon angioplasty devices for carrying out angiographic procedures as they are minimally invasive. Since these devices improve the quality of life, offer better patient healthcare benefits, and minimize hospital stays, its demand among the patients will increase substantially during the predicted period.

Competitive landscape and key vendors

The global angioplasty balloons market will exhibit steady growth and is characterized by the presence of

August 03, 2016 | 72 Pages | SKU: IRTNTR10067

Overview of the global flow diversion aneurysm treatment market

Technavio’s market research analyst have predicted that the global flow diversion aneurysm treatment market will grow at a CAGR of more than 14% by 2020. Flow diversion aneurysm stenting is one of the most widely accepted minimally invasive (MI) procedures for the treatment of intracranial aneurysm. Surgeons, interventional cardiologists, radiologists, and neurologists have the expertise to perform this procedure. The growing acceptance of flow diverters by physicians across the globe has led to the increased use of other endovascular stents. Many hospitals and healthcare centers worldwide are recommending the procedure to people with carotid artery stenosis. Also, several vendors are focusing on getting clinical data and findings that support the adoption of flow diverters, which will enable manufacturers and researchers to develop new technologies for treating intracranial aneurysm. The growing demand for minimally invasive endovascular surgeries will significantly contribute to the growth of the global flow diversion aneurysm treatment market during the predicted period.

According to this market research report, the products available for flow diversion aneurysm treatment are in the initial stages of approval, and over 80% of the products present in the market have got CE mark approval. Regions such as Germany and Western Europe account for the maximum number of flow diversion aneurysm treatment diverters in the market. Several pure play companies such as Phenox and Acandis are performing rigorous clinical testing to

July 22, 2016 | 56 Pages | SKU: IRTNTR9084

Overview of the global atherectomy devices market

Atherectomy is a minimally invasive surgical procedure for the plaque that blocks vein grafts or coronary arteries. The recent rise in the incidence of peripheral artery disease across the globe, especially among the aging population, has boosted the demand for atherectomy procedures during the forecast period. Since many medical facilities are using atherectomy procedures to treat the peripheral artery disease, it will increase the demand and sales of atherectomy devices in the next few years. Technavio’s market research analyst predicts that the global atherectomy devices market will grow at a CAGR of more than 5% by 2020.

Owing to technological advancements and product innovations, vendors have been compelled to replace traditional atherectomy devices with new technologies like laser-based atherectomy devices. These advanced devices are more efficient and have minimal complications.  Vendors have also come up with devices that offer advanced features such as improved physician controls, ergonomics, and manufacturability. For instance, Avinger’s advanced version of Pantheris lumivascular atherectomy system is the first image-guided atherectomy device. The increase in demand for such innovative devices among physicians will augment this market’s growth potential during the forecast period.

Segmentation by technology and analysis of the atherectomy devices market

  • Directional atherectomy
  • Rotational atherectomy
  • Orbital atherectomy
  • Laser atherectomy

Orbital atherectomy is an advanced technology that helps remove plaque in difficult-to-treat patient population. The high revolving speed of orbital atherectomy devices makes the tissue remains small for their harmless excretion through the circulatory system and restricts any possibility for distal embolic complications. These